Pharmaceuticals
-
Oedema drug improves autism symptoms
A drug prescribed to treat oedema improves some of the symptoms in young children with autism, according to a study published today. Read more
-
Antibiotic outlook bleak – WHO
The outlook for the arrival of effective new antibiotics is bleak, according to a new analysis by the World Health Organisation. Read more
-
Concerns over racial disparities in dementia treatment
Black and Asian people with dementia in the UK do not receive the same quality of care as white patients with the same condition, a new study claims today. Read more
-
NHS hope for histology independent cancer drugs
The NHS in England is close to approving its first histology independent cancer treatment, regulators said today. Read more
-
Brain blood flow regulation revealed
Scientists have gained an insight into how the brain monitors and regulates its blood supply, independent of the body-wide blood pressure control system. Read more
-
NHS should not prescribe melatonin’
The NHS should not prescribe melatonin for jetlag because there is little evidence it relieves the symptoms of jetlag, according to an expert review published today. Read more
-
Chemotherapy reduction for male cancer patients
Men who undergo surgery for testicular cancer may be able to halve the amount of preventative chemotherapy they take, British researchers have reported. Read more
-
Anastrozole recommended for some post-menopausal women to stop cancer
Anastrozole should be the preventive drug recommended for post-menopausal women at increased risk of developing breast cancer, according to the findings of a new international study today. Read more
-
STI challenge for PrEP
Programmes providing pre-exposure prophylaxis to prevent HIV infection need to spend time on patients’ overall sexual health, according to a World Health Organisation study. Read more
-
Seeing cancer as a chronic disease
The public need to stop expecting "cures" for cancer and recognise it can often be managed as a long-term disease, British experts say today. Read more
